How do you speed up oncology literature screening while ensuring validated results? In this case study, MadeAi partnered with Roche to accelerate primary screening for PD-L1+ NSCLC studies using a GenAI-enabled, protocol-driven approach. By translating PICOS criteria into 12 algorithmic inclusion tags and combining AI-driven screening with parallel manual validation, the team achieved 95.5% AI-to-manual…